A new study finds that the HPV vaccine prevents genital warts and precancerous changes to the cervix in young women ages 14 to 17. Not only does this provide further evidence of the vaccine’s efficacy; it suggests that early vaccination is important.
Gardasil 9, the newest version of the HPV vaccine to be approved by the FDA, has the potential to prevent 90 percent of cases of cervical, vulvar, vaginal, and anal cancers, but only if the vaccine becomes more widely accepted.
Between the high-tech sex toys, transplanted uteri, lab-grown penises, and perils of hookup apps, 2014 sometimes sounded like a science fiction novel. But we can’t forget the news about IUDs and STIs that came out this year, either.
A study this week adds to the large body of research that shows teens who have received the HPV vaccine are no more likely to engage in sexual activity or suffer consequences such as unintended pregnancy or STIs than their un-vaccinated peers.
Despite a mounting body of evidence to the contrary, there continues to be a fear among adults that vaccinating young people against an STD is akin to giving them a license to have sex. Yet another study promises this isn’t going to happen.
This week, the Illinois senate took up a bill requiring that sex education be medically accurate, West Virginia took on teen sexting, and a new study suggested we may need to change our HPV messages if we want more women to get the vaccine.
The argument that access to sexual health care or information causes promiscuity is offensive to women and has been proven false time and again. Yet it seems unlikely that it we will end anytime soon.
A study finds that the HPV vaccine doesn’t lead to more sex; another confirms that women who stop using condoms when they start hormonal birth control and don’t go back to condoms if they stop hormonal methods.